Safety Improvement
Delivered best safety performance in more than a decade with the lowest overall injury rate in the period, highlighting disciplined site execution and workforce focus on safety.
Stronger-than-expected Q4 Volumes (TiO2 & Zircon)
TiO2 volumes in Q4 reached the highest point of the year and increased 9% sequentially; zircon volumes increased 42% sequentially, driving sequential revenue increases of +5% for TiO2 and +32% for zircon.
Cash Preservation and Q4 Free Cash Flow
Maintained disciplined cash and inventory management; generated $53 million of free cash flow in Q4 despite a challenging environment and targeted working capital initiatives that produced a $133 million working capital source in Q4 (excluding restructuring payments).
Sustainable Cost Improvement Progress
Exited 2025 with more than $90 million of run-rate savings (three times the original target) from the cost improvement program, tracking >2,000 initiatives with >500 delivering savings; on pace for the high end of $125–$175 million run-rate target by exit 2026.
Liquidity & Balance Sheet Actions
Liquidity increased to $674 million as of Dec 31, 2025 (including $199 million cash); executed opportunistic $400 million senior secured note offering in September; weighted average interest rate ~6% and ~77% of interest rates fixed through 2028; next major debt maturity not until 2029.
Operational and Portfolio Actions to Improve Long-Term Cost Structure
Announced closures of Botlek and Fuzhou pigment plants to streamline footprint and improve long-term cost position; expected run-rate fixed cost savings of ~ $30M (Botlek) and ~$15M (Fuzhou) annually.
Commercial Momentum and Pricing Initiatives
Company implemented TiO2 price increases beginning Q1 2026 and expects TiO2 pricing to be up ~2%–4% sequentially (mix + announced increases); zircon pricing stabilizing in Q1 with announced increases expected to be implemented in Q2.
Mining and Rare Earths Progress
Commenced mining at Fairbreeze and began commissioning of East OFS; advanced rare earths strategy with conditional, nonbinding financing discussions (EFA and Ex-Im Bank) for a cracking and leaching facility in Australia and progress on a definitive feasibility study.
2026 Guidance and Cash Outlook
Guided Q1 2026 EBITDA of $55M–$65M, CapEx expected to moderate to ~$260M in 2026, and management expects positive free cash flow for full-year 2026 assuming realized pricing and working capital improvements.